세계의 인공 신장 시장(2023-2030년)

Global Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals) Forecast Period (2023-2030)

The global artificial kidney market is anticipated to grow at a considerable CAGR of 13.0% during the forecast period. The market growth is attributed to factors including the increasing number of patients suffering from diseases such as Acquired Cystic Kidney Disease, Glomerular Diseases, Diabetes Insipidus, and others, globally. Moreover, the less availability of kidney donors is another key factor intensifying the market growth. For instance, according to the Center for Disease Control and Prevention (CDC), in 2021 more than 1 in 7, that is 15% of US adults or 37 million people are diagnosed with chronic kidney disease (CKD).

The increasing R&D activities for manufacturing the innovative artificial kidney is anticipated to further bolster the growth of the artificial kidney market. For instance, in June 2021, UCLA Health published an article stating "Artificial Kidney in Development Aims to Offer Dialysis Free Life". As per the article, the US Department of Health and Human Services (HHS) partnered with the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis and treatment of kidney diseases. For which, currently, both the organizations are working together to develop waterless, dialysate-free technology , supports in creating the 1st implantable artificial kidney by 2026.

Segmental Outlook

The global artificial kidney market is segmented based on its device type, dialysis type, and end-user. Based on device type, the market is bifurcated into wearable artificial kidney and implantable artificial kidney. Based on dialysis type, the market is segmented into hemodialysis and peritoneal dialysis. Further, based on the end-user, the market is sub-segmented into dialysis centers, specialty clinics, and hospitals. Among the end-user, the hospitals sub-segment is anticipated to have a significant market share owing to the expansion of kidney disease related healthcare facilities and hospitals across the globe.

Hemodialysis Sub-Segment to Hold a Major Market Share in the Global Artificial Kidney Market

Among the dialysis type segment, hemodialysis is anticipated to hold a prominent market share of the global artificial kidney market. Hemodialysis is a treatment to filter wastes and water from the blood. It helps in controlling blood pressure (BP) and balance important minerals, such as potassium, sodium, and calcium, in blood. The segmental growth is attributed to the rising number of end-stage renal diseases (ESRD) along with the increasing incidences of diabetes and hypertension among the global population. According to the National Institute of Health (NIH), around 786,000 people in the US are living with ESRD in 2021. Of which, 71% are on dialysis and 29% are expected to opt kidney transplant.

Regional Outlooks

The global artificial kidney market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the European region is anticipated to grow at a considerable rate in the artificial kidney market during the forecast period owing to the increasing healthcare expenditure coupled with the rising prevalence of kidney diseases. The general government health expenditure in the European Union (EU) region amounted nearly around $1.3 trillion in 2021, which is around 8% of the total gross domestic product of the region (GDP).

Global Artificial Kidney Market Growth, by Region 2023-2030

Source: OMR Analysis

The Asia-Pacific Region is Anticipated to Hold a Significant Share in the Global Artificial Kidney Market

Among all regions, the Asia-Pacific region is anticipated to account for a significant share of the artificial kidney market during the forecast period. Factors bolstering the market growth includes the increasing number of people suffering with chronic kidney diseases and increasing investment by regional key market players to enhance the production capacity of artificial kidneys. For instance, in December 2020, Japanese medical device manufacturer Nipro Asia spent around $958 million to ramp-up the global production facility of artificial kidneys used in dialysis machines. The investment, which runs through fiscal 2026, will go mainly toward factories in Vietnam and the home market. Total output capacity will reach 12 million units a month. This expansion will support Nipro's plans to boost dialyzer sales in emerging countries, where diabetes patients have increased with economic growth.

Market Players Outlook

The major companies serving the global artificial kidney market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Medtronic plc and DaVita Inc. partnered to form a new, independent kidney care-focused medical device company NewCoto enhance the patient treatment experience and improve overall outcomes.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global artificial kidney market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

Current Industry Analysis and Growth Potential Outlook

• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.Cardinal Health
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.Medtronics plc
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.Siemens Medical Solutions USA Inc.
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Artificial Kidney Market by Device Type
  • 4.1.1.Wearable Artificial Kidney
  • 4.1.2.Implantable Artificial Kidney
• 4.2.Global Artificial Kidney Market by Dialysis Type
  • 4.2.1.Hemodialysis
  • 4.2.2.Peritoneal Dialysis

Global Artificial Kidney Market by End-User

Dialysis Centers

• 4.3.2.Specialty Clinics
• 4.3.3.Hospitals

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World

6.Company Profiles

• 6.1.Asahi Kasei Corp.
• 6.2.AWAK Technologies
• 6.3.B. Braun Melsungen AG
• 6.4.Baxter International, Inc.
• 6.5.DaVita Inc.
• 6.6.Dynarex Corp.
• 6.7.Fresenius Medical Care AG & Co.
• 6.8.Kawasumi Laboratories, Inc.
• 6.9.Medline Industries, LP.
• 6.10.Merit Medical Systems.
• 6.11.Nanodialysis
• 6.12.Nikkiso Co., Ltd.
• 6.13.Organ Recovery Systems
• 6.14.Transonic
• 6.15.Triomed AB